A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2004
11/10/2004	CN1174973C Schizonepeta lactone and its extraction process and use
11/10/2004	CN1174971C Morpholine ethers
11/10/2004	CN1174956C Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha
11/10/2004	CN1174765C Composite Chinese medicine for treating venereal disease and dermatosis and its preparing method
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester
11/09/2004	US6815461 Method of inhibiting retroviral integrase
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6815446 Administering 8-amino-xanthine derivative as antiasthmatic or antidiarrhea agent
11/09/2004	US6815442 Quinoxalinones for enhancing chemotherapy
11/09/2004	US6815437 Virginiamycins as bactericides; pristinamycin chemical intermediates
11/09/2004	US6815420 Methods of using chemokine beta-6
11/09/2004	US6815414 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
11/09/2004	US6815182 For diagnosis/therapy/prophyaxis of infections/diseases; vaccines; genetic engineering
11/09/2004	US6814971 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a bordetella infections and/or a toxigenic pasteuralla infections
11/09/2004	US6814969 Epitopes recognized by t-cells (cd-8/cd-4 antigens) derived from herpetic lesions; fusion proteins; antigen presenting cells; vaccines
11/09/2004	US6814964 Supramolecules containing binding and therapeutic molecules bound to hybridized nucleic acids
11/09/2004	US6814960 Prepared in a solid-phase synthesis using a trityl resin
11/09/2004	US6814955 Aerosol comprises particles of chlordiazepoxide, betahistine, clonidine, testosterone, conjugated estrogens, estrogen esters, estradiol, estradiol esters, ethinyl estradiol, ethinyl estradiol esters, or hyoscyamine.
11/09/2004	US6814954 Delivery of compounds for the treatment of Parkinsons through an inhalation route
11/09/2004	US6814929 Antibacterial composition for diffusing to combat bacteria contained in the air, a method of diffusing such a composition
11/09/2004	CA2280718C Administration of an injectable antibiotic in the ear of an animal
11/09/2004	CA2265824C Antifungal combination therapy
11/09/2004	CA2138137C Diphtheria toxin vaccines
11/09/2004	CA1341464C Hepatitis e, an enterically transmitted hepatitis viral agent
11/04/2004	WO2004095023A1 Novel method of screening
11/04/2004	WO2004094991A2 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
11/04/2004	WO2004094599A2 Disease prevention and vaccination following thymic reactivation
11/04/2004	WO2004094462A2 Methods of peptide preparation
11/04/2004	WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE
11/04/2004	WO2004094424A1 Nitrogen-containing heterocyclic compounds and use thereof
11/04/2004	WO2004094386A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
11/04/2004	WO2004093904A2 Modified live vaccines comprising bhv-1(ibr) and/or bvdv pregnant and nursing cattles
11/04/2004	WO2004093903A2 Methods and compositions for immunomodulation using cd1 antigens
11/04/2004	WO2004093888A1 Charged polysaccharides resistant to lysosomal degradation during kidney filtration and renal passage and their use to treat or prevent infection by coronaviruses
11/04/2004	WO2004093887A1 Compositions comprising hyaluronic acid for the prevention of urogenital infections
11/04/2004	WO2004093885A1 Compositions containing lactulose for treating potavirus infections
11/04/2004	WO2004093876A2 Composition containing berberine or a derivative thereof and an antimicrobial agent or an antibiotic agent, and their use for treating oral pathogens and other disorders
11/04/2004	WO2004093863A1 A composition comprising an edible acid or its acidic salt and the use thereof
11/04/2004	WO2004093862A1 Pharmaceutical composition comprising edible acids or the acid salts and its use
11/04/2004	WO2004093860A1 Inhibitors of sars related coronavirus proteinase
11/04/2004	WO2004093859A1 Dilution-type sterilizer composition
11/04/2004	WO2004093825A2 Methods for obtaining colonization factors from bacterial strains
11/04/2004	WO2004093798A2 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
11/04/2004	WO2004073703B1 Glycinamide derivative for inhibiting hiv replication
11/04/2004	WO2004058142A3 Improved combine vaccine against mycoplasma hyopneumoniae and porcine viruses
11/04/2004	WO2004035008A3 Treatment of infections and other disorders
11/04/2004	WO2004024173A3 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism
11/04/2004	WO2004003000A3 1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
11/04/2004	WO2003089903A3 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
11/04/2004	WO2003086324A3 Preparation and use of a stable formulation of allosteric effector compounds
11/04/2004	WO2003078431A8 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
11/04/2004	WO2003060091A3 Selective melanin-concentrating hormone type -1 receptor agonists
11/04/2004	WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/04/2004	WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004	US20040220388 Novel heterodimeric fusion proteins
11/04/2004	US20040220276 Coated granules of allylamine-or benzylamine-anti-mycotics
11/04/2004	US20040220260 efficacious in producing nitric oxide in the skin, the mucous membranes or the scalp; treatment of psoriasis lesions and/or chronic ulcers; i.e. Ascorbyl 2-O-cinnamate
11/04/2004	US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004	US20040220209 Novel imidazopyridine compounds with therapeutic effect
11/04/2004	US20040220207 Chemokine receptor binding heterocyclic compounds
11/04/2004	US20040220204 mixture of fatty ester, alkylene carbonate, butylene glycol, diethylene glycol, monoalkyl ether and thickeners
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220168 Process for the preparation of imipenem
11/04/2004	US20040220164 Triaza compound immunoregulatory agents
11/04/2004	US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders
11/04/2004	US20040220146 Methods and compositions for treating fungal infections
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040220123 therapy for bactericide infections which are drug resistance, antibiotic resistance; anticancer agents; hybrid nucleic acids;
11/04/2004	US20040220122 Administering teichoplanin; remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection
11/04/2004	US20040220120 mixture of lactone and carrier;
11/04/2004	US20040220107 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
11/04/2004	US20040220096 Method and compositions for treating dopaminergic and gabanergic disorders
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040220083 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body
11/04/2004	US20040220076 Prevention of recurrent viral disease
11/04/2004	US20040219672 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells
11/04/2004	US20040219639 Immunogenic fusion polypeptide comprising lytic epitopes for use in developing vaccine for prevention of mastitis in dairy cattle; veterinary medicine; immunotherapy
11/04/2004	US20040219597 Using cytokeratin marker peptides as diagnostic, prognostic and treatment tools for inflammations and/or infections in animals or humans; sepsis prevention; veterinary medicine
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219200 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
11/04/2004	US20040219199 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
11/04/2004	US20040219181 Sustained release drug delivery devices with coated drug cores
11/04/2004	US20040219176 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
11/04/2004	US20040219173 Administring the sodium chloride formulation to the human's upper gastro-intestinal tract so as to introduce the sodium chloride formulation to the metabolism of the human with periodical repetition
11/04/2004	US20040219168 Preparing preferential cells from blood mononucler cells in culture; obtain monocytes, incubate with interferon; use as biodrugs treating viral infections, lymphoma, neoplastic disease induced by Epstein-Barr virus, therapeutic vaccination
11/04/2004	US20040219165 Streptococcus pneumoniae antigens
11/04/2004	US20040219154 Monoclonal antibodies directed against hepatitis b viruses
11/04/2004	US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004	CA2523207A1 Germicidal antiseptic composition for dilution
11/04/2004	CA2522891A1 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
11/04/2004	CA2522819A1 Polyvalent protein complex
11/04/2004	CA2522703A1 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/04/2004	CA2521531A1 Pharmaceutical composition comprising edible acids or the acid salts and its use
11/04/2004	CA2520647A1 Compositions containing lactulose for treating rotavirus infections
11/04/2004	CA2519164A1 Compositions comprising hyaluronic acid for the prevention of urogenital infections
11/04/2004	CA2518180A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
11/04/2004	CA2517134A1 Methods for obtaining colonization factors from bacterial strains
11/03/2004	EP1473369A2 Compositions and methods for delivery of genetic material

1 ... 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 ... 1798